CSIMarket


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Biogen Inc

BIIB's Fundamental analysis






Biogen Inc 's sales fell by -22.3 % in IV. Quarter 2020 from the same quarter a year ago. Ranking at No. 1970

Biotechnology & Drugs industry recorded growth of revenues by 14.69 %

Biogen Inc 's net profit deacreased by -75.17 % in IV. Quarter 2020 year on year, to $358 millions.

More on BIIB's Growth


Biogen Inc
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Biogen Inc realized cash outflow of $ -10.72per share in trailing twelve-month period.
Company
11.39
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 3.19.
Biotechnology & Drugs industry's Price to Sales ratio is at 5.21.
With annual estimated revenue deacrease of -17 % for 2015, Company's P/S ratio deteriorated to 3.84.

More on BIIB's Valuation
 
 Total Debt (Millions $) 7,426
 Dividend TTM ($) 0.46 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,816,838
 Net Income/Employee (TTM) $ 548,716
 Receivable Turnover (TTM) 6.59
 Tangible Book Value (Per Share $) 11.95

Biogen Inc
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Biogen Inc realized cash outflow of $ -10.72per share in trailing twelve-month period.
Company
11.39
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 3.19.
Biotechnology & Drugs industry's Price to Sales ratio is at 5.21.
With annual estimated revenue deacrease of -17 % for 2015, Company's P/S ratio deteriorated to 3.84.

More on BIIB's Valuation

 Market Capitalization (Millions $) 42,891
 Shares Outstanding (Millions) 154
 Employees 7,400
 Revenues (TTM) (Millions $) 13,445
 Net Income (TTM) (Millions $) 4,061
 Cash Flow (TTM) (Millions $) -1,652
 Capital Exp. (TTM) (Millions $) -477
 Total Debt (Millions $) 7,426
 Dividend TTM ($) 0.46 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,816,838
 Net Income/Employee (TTM) $ 548,716
 Receivable Turnover Ratio (TTM) 6.59
 Tangible Book Value (Per Share $) 11.95

 Market Capitalization (Millions $) 42,891
 Shares Outstanding (Millions) 154
 Employees 7,400
 Revenues (TTM) (Millions $) 13,445
 Net Income (TTM) (Millions $) 4,061
 Cash Flow (TTM) (Millions $) -1,652
 Capital Exp. (TTM) (Millions $) -477




  Ratio
   Capital Ratio (MRQ) 1.84
  Total Debt to Equity (MRQ) 0.69
  Tangible Leverage Ratio (MRQ) 7.57
  Asset Turnover Ratio (TTM) 0.53
  Inventory Turnover Ratio (TTM) 1.85





Biogen Inc net profit margin of 12.53 % is currently ranking no. 15 in Biotechnology & Drugs industry, ranking no. 85 in Healthcare sector and number 838 in S&P 500.

More on BIIB's Key Ratios





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KDMN's Profile

Stock Price

KDMN's Financials

Business Description

Fundamentals

Charts & Quotes

KDMN's News

Suppliers

KDMN's Competitors

Customers & Markets

Economic Indicators

KDMN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071